Literature DB >> 9059880

Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone-marrow grafts.

T George1, Y Y Yu, J Liu, C Davenport, S Lemieux, E Stoneman, P A Mathew, V Kumar, M Bennett.   

Abstract

Natural killer (NK) cells of inbred mice reject allogeneic bone-marrow cells, and NK cells of F1 hybrid mice can reject parental bone-marrow cells (hybrid resistance). In some cases these patterns of rejection can be mimicked in vitro by utilizing IL-2 cultured NK effector cells and allogeneic or parental T-lymphoblasts as target cells. Lysis of allogeneic and parental targets in vitro can be explained on the basis of the missing self hypothesis. Subsets of NK cells that bear non-overlapping MHC class I inhibitory receptors belonging to the Ly49 family lyse allogeneic targets because they do not express self class I molecules of the NK cell donor. Parental strain targets are lysed because they do not express all of the self class I antigens of the F1 hybrid, and hence fail to deliver inhibitory signals to all subsets of F1 NK cells. The expression of Ly49 receptors on NK cells is regulated by host MHC to ensure maximal sensitivity to alterations in self class I molecules and to prevent autoreactivity. In many instances, however, the rejection of allogeneic bone marrow cells in vivo cannot be readily explained by the missing self hypothesis. In these instances, it appears that rejection is initiated by class I MHC receptors on NK cells that recognize allogeneic class I molecules as non-self, and activate rather than inhibit NK cell function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059880     DOI: 10.1111/j.1600-065x.1997.tb00937.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  8 in total

1.  The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.

Authors:  Joshua N Beilke; Jonathan Benjamin; Lewis L Lanier
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

Review 2.  Ly49 gene expression in different inbred mouse strains.

Authors:  A P Makrigiannis; S K Anderson
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Hematopoietic cell transplantation for treatment of primary immune deficiencies.

Authors:  Lauri Burroughs; Ann Woolfrey
Journal:  Cell Ther Transplant       Date:  2010-08-31

4.  NK cells in the CD19- B220+ bone marrow fraction are increased in senescence and reduce E2A and surrogate light chain proteins in B cell precursors.

Authors:  Anne M King; Patricia Keating; Anjali Prabhu; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2009-03-24       Impact factor: 5.432

5.  Expression of major histocompatibility complex class I proteins and their antigen processing chaperones in mouse embryonic stem cells from fertilized and parthenogenetic embryos.

Authors:  P W Lampton; R J Crooker; J A Newmark; C M Warner
Journal:  Tissue Antigens       Date:  2008-09-05

6.  Acquisition of Ly49 receptor expression by developing natural killer cells.

Authors:  J R Dorfman; D H Raulet
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

7.  Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors.

Authors:  A Sjöström; M Eriksson; C Cerboni; M H Johansson; C L Sentman; K Kärre; P Höglund
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

8.  Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation.

Authors:  J I Rodriguez-Barbosa; M C Ferreras; L Buhler; N D Jones; P Schneider; J A Perez-Simon; M L Del Rio
Journal:  MAbs       Date:  2018-09-05       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.